Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/08/18 → 30/09/26 |
Funding
- Cancer Prevention Research Trust: £375,869.19
Research output
- 3 Article
-
Combination of phenethyl isothiocyanate and dasatinib inhibits hepatocellular carcinoma metastatic potential through FAK/STAT3/Cadherin signalling and reduction of VEGF secretion
Strusi, G., Suelzu, C. M., Weldon, S., Giffin, J., Münsterberg, A. E. & Bao, Y., Oct 2023, In: Pharmaceutics. 15, 10, 2390.Research output: Contribution to journal › Article › peer-review
Open AccessFile5 Citations (Scopus)16 Downloads (Pure) -
Phenethyl isothiocyanate and dasatinib combination synergistically reduces hepatocellular carcinoma growth via cell cycle arrest and oxeiptosis
Strusi, G., Suelzu, C., Horwood, N., Münsterberg, A. E. & Bao, Y., 4 Oct 2023, In: Frontiers in Pharmacology. 14, 1264032.Research output: Contribution to journal › Article › peer-review
Open AccessFile7 Citations (Scopus)22 Downloads (Pure) -
Sulforaphane mediates glutathione depletion via polymeric nanoparticles to restore cisplatin chemosensitivity
Xu, Y., Han, X., Li, Y., Min, H., Zhao, X., Zhang, Y., Qi, Y., Shi, J., Qi, S., Bao, Y. & Nie, G., 26 Nov 2019, In: ACS Nano. 13, 11, p. 13445-13455 11 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile138 Citations (Scopus)44 Downloads (Pure)